The adenosine A2A receptor knockout mouse: A model for anxiety?

International Journal of Neuropsychopharmacology

Volumn 1, Issue 2, 1998, Pages 187-190

  Deckert, Jürgen ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Adenosine A2A; Anxiety; Behaviour; Knockout mouse; Psychiatric disorders

Indexed keywords

EID: 0004972611     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145798001217     Document Type: Article

References (17)

1. Barraco RA, Janusz CA, Schoener EP, Simpson LL (1992). Cardiorespiratory function is altered by picomole injections of 5′N-ethylcarboxamido adenosine into the tractus solitarius of rats. Brain Research 507, 234-246.
2. Boulenger JP, Uhde TW, Wolff EA, Post RM (1984). Increased sensitivity to caffeine in patients with panic disorder: preliminary evidence. Archives of General Psychiatry 40, 1067-1071.
3. Deckert J, Gleiter CH (1990). Adenosinergic psychopharmaceuticals: just an extra cup of coffee? Journal of Psychopharmacology 41, 83-187.
4. 2a receptor gene: relation to potential schizophrenia loci on chromosome 22q and exclusion from the CATCH 22 region. Human Genetics 99, 326-328.
5. 2a gene to the development of disease. Molecular Psychiatry 3, 81-85.
6. 2aAR) gene: systematic mutation screening in patients with schizophrenia. Journal of Neural Transmission 103, 1447-1455.
7. Dragunow M (1986). Endogeneous anticonvulsant substances. Neuroscience and Biobehavioral Reviews 10, 229-244.
8. 2 receptors in the ventral striatopallidal system. Implications for the treatment of schizophrenia. Neuroscience 63, 765-773.
9. Gorman JM, Fyer MR, Goetz R, Askanazi J, Liebowitz MR, Fyer AJ, Kinney J, Klein DF (1988). Ventilatory physiology of patients with panic disorder. Archives of General Psychiatry 45, 31-39.
10. 2a receptor. Nature 388, 674-678.
11. Lucas PB, Pickar D, Kelsoe J, Rapaport M, Pato C, Hommer D (1990). Effects of the acute administration of caffeine in patients with schizophrenia. Biological Psychiatry 28, 35-40.
12. 2 receptors: selective localization in the human basal ganglia and alteration with disease. Neuroscience 42, 697-706.
13. Sawynok J, Sweeney MJ (1989). The role of purines in nociception. Neuroscience 32, 557-569.
14. Schnackenburg RC (1973). Caffeine as a substitute for schedule II stimulants in hyperkinetic children. American Journal of Psychiatry 130, 796-798
15. Snyder SH (1985). Adenosine as a neuromodulator. Annual Reviews in Neuroscience 8, 103-124.
16. Stout JT, Caskey CT (1988). The Lesch-Nyhan syndrome: clinical, molecular and genetic aspects. Trends in Genetics 4, 175-178.
17. 2A receptors underlies the behavioral-activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFi-A and NGFI-B in caudate-putamen and nucleus accumbens. Neuroscience 79, 753-764